EGFR and laryngotracheoesophageal cleft: Regarding EGFR disease, miRNA-197 and miRNA-184 upregulation has also been observed in this subpopulation of LC patients, concluding the potential value of these components as biomarkers associated to a higher risk of EGFR mutation.